<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PUKRFVWH</identifier><date>2012</date><creator>Grabnar, Iztok</creator><relation>documents/doc/P/URN_NBN_SI_doc-PUKRFVWH_001.htm</relation><relation>documents/doc/P/URN_NBN_SI_doc-PUKRFVWH_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PUKRFVWH_001.txt</relation><format format_type="issue">4</format><format format_type="volume">63</format><format format_type="type">article</format><format format_type="extent">str. 211-215</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3312241</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PUKRFVWH</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">klinične študije</subject><subject language_type_id="slv">kritična ocena</subject><subject language_type_id="slv">raziskave</subject><subject language_type_id="slv">tveganje</subject><subject language_type_id="slv">uporabnost</subject><title>From controlled clinical trials to evidence-based pharmacotherapy</title><title>Od kontroliranih kliničnih raziskav do na dokazih temelječega zdravljenja z zdravili</title></Record>